Foretinib
id:
foretinib-180-4049117
title:
Foretinib
text:
Foretinib is an experimental drug candidate for the treatment of cancer. It was discovered by Exelixis and is under development by GlaxoSmithKline. About 10 Phase II clinical trials have been run. As of October 2015 it appears development has been discontinued. Foretinib is an inhibitor of the kinase enzymes c-Met and vascular endothelial growth factor receptor 2 (VEGFR-2).
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Foretinib
date created:
2011-08-05T15:05:31Z
date modified:
2024-09-05T09:39:56Z
main entity:
{"identifier":"Q5469311","url":"https://www.wikidata.org/entity/Q5469311"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/f2/Foretinib.svg","width":512,"height":203}
fields total:
13
integrity:
16